ARCHIVES

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

This article is from The Cancer Letter archive.

Vol. 29 No. 36 | October 3, 2003

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 7, 2000

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989

NCI-Approved Clinical Trials

April 29, 2005

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008